Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markert

Showing results (261-270 of 268) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 268 results.
Nature Communications|April 24, 2025
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunityUpasana Sahu, Matthew P Mullarkey, Sara A Murphy, et al.
Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.
Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.
Oncoimmunology|November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibitionJoshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Journal of Translational Genetics and Genomics|March 28, 2022
Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virusM R Chambers, J B Foote, R T Bentley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
The New England Journal of Medicine|April 10, 2021
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade GliomasGregory K Friedman, James M Johnston, Asim K Bag, et al.
Cell Reports|February 14, 2019
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing RadiationMutsuko Minata, Alessandra Audia, Junfeng Shi, et al.
Pageof 27

Showing results (261-270 of 268) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 268 results.
Nature Communications|April 24, 2025
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunityUpasana Sahu, Matthew P Mullarkey, Sara A Murphy, et al.
Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.
Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.
Oncoimmunology|November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibitionJoshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Journal of Translational Genetics and Genomics|March 28, 2022
Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virusM R Chambers, J B Foote, R T Bentley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
The New England Journal of Medicine|April 10, 2021
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade GliomasGregory K Friedman, James M Johnston, Asim K Bag, et al.
Cell Reports|February 14, 2019
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing RadiationMutsuko Minata, Alessandra Audia, Junfeng Shi, et al.
Pageof 27